Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00840983 · ClinicalTrials.gov registry record · Phase 1

Effects of Delayed Cord Clamping in Very Low Birth Weight Infants

A Phase 1 study, sponsored by University of Rhode Island.

Completed
Registry status
Phase 1
Development phase
72
Enrollment target

NCT00840983: Completed Phase 1 study, sponsored by University of Rhode Island.

NCT00840983 is a Phase 1 study that has completed, run by University of Rhode Island. The registered enrollment target is 72 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (20% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00840983, a Phase 1 study, has completed, sponsored by University of Rhode Island.

COMPLETED
Registry status
Phase 1
Development phase
72 participants
Enrollment target

Study Summary

The purpose of this study was to see if a brief delay in cord clamping for 30 to 45 seconds would result in higher hematocrit levels, fewer transfusions, healthier lungs, and better motor function at 40 wks and 7 months of age.

Interventions

  • PROCEDURE delayed cord clamping

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2003-08
Est. Completion 2006-12
Phase Phase 1
University of Rhode Island

29 total trials

What the finished NCT00840983 record still lists

NCT00840983 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (20% higher).

The record links to 0 conditions, and to 1 intervention - of which delayed cord clamping is the first listed.

NCT00840983 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00840983 about?

NCT00840983 is a clinical study titled "Effects of Delayed Cord Clamping in Very Low Birth Weight Infants". The purpose of this study was to see if a brief delay in cord clamping for 30 to 45 seconds would result in higher hematocrit levels, fewer transfusions, healthier lungs, and better motor function at 40 wks and 7 months of age.

What is the current status of trial NCT00840983?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2003-08. Estimated completion is 2006-12.

What interventions are being tested in trial NCT00840983?

The interventions under investigation include: delayed cord clamping (PROCEDURE).

Who is sponsoring clinical trial NCT00840983?

This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00840983's enrollment target sits among peer trials

72 736th of 2000 higher than 1,254 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00840983, the US trial registry maintained by the National Library of Medicine. NCT00840983 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.